of tomorrow At LEO Pharma, our mission transcends the conventional. We're on an ambitious path to become the leaders in medical... Pharma, a global leader in medical dermatology, as we go beyond the skin to make a lasting impact. Our innovative approach...
Medical Director, Endocrinology ICON plc is a world-leading healthcare intelligence and clinical research..., and we welcome you to join us on our mission to shape the future of clinical development We are currently seeking a Medical Director with a specialism...
; Employee savings plan; Gold medical package; International operating environment; Language classes; Soft skills trainings... expect generous medical care, insurance and savings plans among other perks. You’ll have access to flexible Work Program...
transcends the conventional. We're on an ambitious path to become the leaders in medical dermatology worldwide. In Data... or CV on why this position has your interest. Beyond the skin Join LEO Pharma, a global leader in medical dermatology, as we go beyond the...
UK Athletics and its former head of sport Keith Davies are charged with manslaughter over the death of Paralympian Abdullah Hayayei. Continue Reading »
The Quadrant Future Tek IPO was subscribed 48.99 times as of 5:00 PM IST on the second day of its offering, according to data from the BSE. Continue Reading »
Dr. Agarwal's, Casagrand Premier and Regreen Excel EPC are among the companies which received approval from the markets regulator to raise funds via IPO. Continue Reading »
Casagrand Premier Builder, a Chennai-based real estate firm, has received SEBI's nod for an IPO. The offering includes a fresh share sale of ₹1,000 crore and an OFS of ₹100 crore. Continue Reading »
A continued focus on order inflows, which typically leads to a sentimental uptick in stocks, might lead investors to miss the wood for the trees. Continue Reading »
Small-cap stock: Shares of this small cap stock has given 22.03 per cent returns year-to-date. The company announced board meeting date to discuss stock split, bonus and dividend issue; Check details. Continue Reading »
In 2024, the Indian stock market saw the BSE Sensex rise 8.17% and NSE Nifty50 climb 8.8%, despite challenges like foreign investor selling and geopolitical tensions. Strong macroeconomic stability and earnings growth are expected to support market performance in the coming years. Continue Reading »